Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 1;106(1):153-167.
doi: 10.1210/clinem/dgaa675.

Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records

Affiliations

Characterizing the Clinical and Genetic Spectrum of Polycystic Ovary Syndrome in Electronic Health Records

Ky'Era V Actkins et al. J Clin Endocrinol Metab. .

Abstract

Context: Polycystic ovary syndrome (PCOS) is one of the leading causes of infertility, yet current diagnostic criteria are ineffective at identifying patients whose symptoms reside outside strict diagnostic criteria. As a result, PCOS is underdiagnosed and its etiology is poorly understood.

Objective: We aim to characterize the phenotypic spectrum of PCOS clinical features within and across racial and ethnic groups.

Methods: We developed a strictly defined PCOS algorithm (PCOSkeyword-strict) using the International Classification of Diseases, ninth and tenth revisions and keywords mined from clinical notes in electronic health records (EHRs) data. We then systematically relaxed the inclusion criteria to evaluate the change in epidemiological and genetic associations resulting in 3 subsequent algorithms (PCOScoded-broad, PCOScoded-strict, and PCOSkeyword-broad). We evaluated the performance of each phenotyping approach and characterized prominent clinical features observed in racially and ethnically diverse PCOS patients.

Results: The best performance came from the PCOScoded-strict algorithm, with a positive predictive value of 98%. Individuals classified as cases by this algorithm had significantly higher body mass index (BMI), insulin levels, free testosterone values, and genetic risk scores for PCOS, compared to controls. Median BMI was higher in African American females with PCOS compared to White and Hispanic females with PCOS.

Conclusions: PCOS symptoms are observed across a severity spectrum that parallels the continuous genetic liability to PCOS in the general population. Racial and ethnic group differences exist in PCOS symptomology and metabolic health across different phenotyping strategies.

Keywords: electronic health record; hormones; phenotyping; polycystic ovary syndrome; polygenic risk scores.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Polycystic ovary syndrome (PCOS) algorithm pipeline. This schematic illustrates the algorithm development steps for the controls and the 4 PCOS algorithms. The Venn diagram illustrates how the algorithm data sets are nested within one another. Each color corresponds with one of the algorithm data sets. ICD, International Classification of Diseases, 9th and 10th revision.
Figure 2.
Figure 2.
Laboratory measurements for polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels for PCOS algorithm cases and controls. Colored boxes represent races. Boxes represent the individuals with lab measurements in the 25th and 75th percentile. Lines above and below the boxes represent the 95th and 5th quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between algorithm cases and controls and brackets display the P values of the statistical test.
Figure 3.
Figure 3.
Comparison of laboratory measurements between White (W), African American (AA), and Hispanic (HIS) polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels for W, AA, and HIS PCOS cases and controls. Colors correspond with each race. Boxes represent the 25th and 75th quartiles. Lines above and below the boxes represent the 95th and fifth quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between races within the PCOS cases and control data sets. Brackets display the P values of the statistical test.
Figure 4.
Figure 4.
Race-stratified laboratory measurements for polycystic ovary syndrome (PCOS) algorithm cases and controls. Box plots of A, body mass index (BMI) measurements; B, insulin levels; C, estradiol levels; and D, free testosterone levels of race stratified PCOS algorithm data sets. Each color corresponds with a race. Boxes represent the 25th and 75th quartiles. Lines above and below the boxes represent the 95th and fifth quartiles. Lines within each box mark the median. Wilcoxon rank sum tests were performed between algorithm cases and controls within each race. Brackets display the P values of the statistical test. CB, coded broad; CN, controls; CS, coded strict; RB, keyword broad; RS, keyword strict.
Figure 5.
Figure 5.
Genetic validation of polycystic ovary syndrome (PCOS) algorithms. Logistic regressions were performed between PCOS case status and PCOS polygenic risk scores (PCOSPRS). The regression models were adjusted for median age and the first 10 principal components. P values are displayed for each regression model. Colors correspond to the genotyped sample used in the analysis. OR, odds ratio.

References

    1. Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 2018;15(11):2589. - PMC - PubMed
    1. Teede H, Gibson-Helm M, Norman RJ, Boyle J. Polycystic ovary syndrome: perceptions and attitudes of women and primary health care physicians on features of PCOS and renaming the syndrome. J Clin Endocrinol Metab. 2014;99(1):E107-E111. - PubMed
    1. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19-25. - PubMed
    1. Azziz R, Carmina E, Dewailly D, et al. ; Task Force on the Phenotype of the Polycystic Ovary Syndrome of The Androgen Excess and PCOS Society . The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456-488. - PubMed
    1. Indran IR, Huang Z, Khin LW, Chan JKY, Viardot-Foucault V, Yong EL. Simplified 4-item criteria for polycystic ovary syndrome: a bridge too far? Clin Endocrinol (Oxf). 2018;89(2):202-211. - PubMed

Publication types

MeSH terms